UK markets closed

Medacta Group SA (0A05.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
110.01-0.48 (-0.44%)
At close: 05:51PM BST

Medacta Group SA

Strada Regina, 34
Castel San Pietro 6874
Switzerland
41 91 696 60 60
https://www.medacta.com

Sector(s)
Industry
Full-time employees1,662

Key executives

NameTitlePayExercisedYear born
Dr. Alberto SiccardiFounder & Non Executive Chairman327.05kN/A1944
Dr. Francesco SiccardiChief Executive Officer1.58MN/A1977
Mr. Corrado FarsettaChief Financial OfficerN/AN/A1968
Gianluca OlgiatiSenior Director of Global MarketingN/AN/AN/A
Asif HussainChief People OfficerN/AN/AN/A
Mr. Alessandro SiccardiChief Supply Chain OfficerN/AN/A1986
Filippo CappelliHead of ITN/AN/AN/A
Giovanni Niccolo GalliChief Commercial OfficerN/AN/AN/A
Massimiliano BernardoniChief Innovation OfficerN/AN/AN/A
Donato CortesiSecretary of the BoardN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.

Description

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine procedures. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Corporate governance

Medacta Group SA’s ISS governance QualityScore as of 1 April 2024 is 8. The pillar scores are Audit: 6; Board: 8; Shareholder rights: 6; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.